Hinova Pharmaceuticals (SHSE:688302) OCF Yield %: -2.27 (As of Jul. 08, 2026)


SHSE:688302 Hinova Pharmaceuticals Inc SHSE:688302
24 GF Score
Price ¥37.77
! 2 Warning Signs
View Full Analysis

What is Hinova Pharmaceuticals OCF Yield %?

Hinova Pharmaceuticals SHSE:688302 -0.21% 24 OCF Yield % is -2.27 as of Jul. 08, 2026. GuruFocus rates SHSE:688302 with a GF Score™ of 24/100. The stock has 2 warning signs investors should review. Among 1,409 Biotechnology companies, Hinova Pharmaceuticals ranks better than 68.84% on this metric.

OCF Yield % is calculated as Cash Flow from Operations divided by Market Capitalization. It is a financial solvency ratio that compares the operating cash flow a company is expected to earn against its market value.

As of today, Hinova Pharmaceuticals's Trailing 12-Month Cash Flow from Operations is ¥-84.75 Mil, and Market Cap is ¥3,739.82 Mil. Therefore, Hinova Pharmaceuticals's OCF Yield % for today is -2.27%.

The historical rank and industry rank for Hinova Pharmaceuticals's OCF Yield % or its related term are showing as below:

SHSE:688302' s OCF Yield % Range Over the Past 10 Years
Min: -13.79   Med: -5.62   Max: -1.82
Current: -2.27

During the past 8 years, the highest OCF Yield % of Hinova Pharmaceuticals was -1.82%. The lowest was -13.79%. And the median was -5.62%.

SHSE:688302's OCF Yield % is ranked better than
68.84% of 1409 companies
in the Biotechnology industry
Industry Median: -7.99 vs SHSE:688302: -2.27

Hinova Pharmaceuticals's OCF Margin % for the quarter that ended in Mar. 2026 was %.

Hinova Pharmaceuticals OCF Yield % Explanation

Similar to Earnings Yield %, OCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high operating cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.

Hinova Pharmaceuticals OCF Yield % Related Terms

Hinova Pharmaceuticals OCF Yield % Historical Data

* Premium members only.

The historical data trend for Hinova Pharmaceuticals's OCF Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Hinova Pharmaceuticals OCF Yield % Chart

Hinova Pharmaceuticals Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
OCF Yield %
Get a 7-Day Free Trial 0.00 -7.89 -4.96 -6.15 -2.24

Hinova Pharmaceuticals Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
OCF Yield % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -4.37 -1.05 -2.45 -2.40 -1.02

SHSE:688302 vs VRTX, REGN, ALNY: OCF Yield % Comparison

For the Biotechnology subindustry, Hinova Pharmaceuticals's OCF Yield %, along with its competitors' market caps and OCF Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Hinova Pharmaceuticals OCF Yield % vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Hinova Pharmaceuticals's OCF Yield % distribution charts can be found below:

* The bar in red indicates where Hinova Pharmaceuticals's OCF Yield % falls into.


SHSE:688302
24GF Score
Hinova Pharmaceuticals Inc SHSE:688302
OCF Yield % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Hinova Pharmaceuticals OCF Yield % Calculation

OCF Yield % is a financial solvency ratio that compares the operating cash flow a company is expected to earn against its market value.

Hinova Pharmaceuticals's OCF Yield % for the fiscal year that ended in Dec. 2025 is calculated as

OCF Yield %=Cash Flow from Operations / Market Cap
=-108.878 / 4868.61672
=-2.24%

Hinova Pharmaceuticals's annualized OCF Yield % for the quarter that ended in Mar. 2026 is calculated as

OCF Yield %=Cash Flow from Operations * Annualized Factor / Market Cap
=-11.128 * 4 / 4358.68432
=-1.02%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about OCF Yield % →
What does a OCF Yield % of -2.27 mean?
Hinova Pharmaceuticals (SHSE:688302) has a OCF Yield % of -2.27 as of Jul. 08, 2026. OCF Yield is calculated as Cash Flow from Operations divided by Market Capitalization. View historical data on Hinova Pharmaceuticals and its competitors. According to the industry distribution chart, Hinova Pharmaceuticals ranks #439 out of 1409 companies in the Biotechnology industry, placing it in the top 31.2%.
Is Hinova Pharmaceuticals' OCF Yield % too high?
Hinova Pharmaceuticals' current OCF Yield % is -2.27. Based on the distribution chart, Hinova Pharmaceuticals ranks #439 out of 1409 companies in the Biotechnology industry, which is above the industry midpoint. Overall, Hinova Pharmaceuticals has a GF Score™ of 24/100, reflecting its overall financial health beyond just this single metric.
How does Hinova Pharmaceuticals' OCF Yield % compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Hinova Pharmaceuticals ranks #439 out of 1409 companies for OCF Yield %. This puts Hinova Pharmaceuticals in the upper half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good OCF Yield % for a Biotechnology company?
A good OCF Yield % depends on the Biotechnology industry context. However, OCF Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high OCF Yield % mean?
A high OCF Yield % can signal that a stock is expensive relative to its fundamentals. OCF Yield is calculated as Cash Flow from Operations divided by Market Capitalization. View historical data on Hinova Pharmaceuticals and its competitors. Hinova Pharmaceuticals's current OCF Yield % is -2.27. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Hinova Pharmaceuticals stock overvalued right now?
Hinova Pharmaceuticals (SHSE:688302) has a current OCF Yield % of -2.27. The current OCF Yield % is -2.27. Hinova Pharmaceuticals' overall GF Score™ is 24/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is OCF Yield % calculated?
OCF Yield % is calculated from a company's financial statements. For Hinova Pharmaceuticals (SHSE:688302), the current OCF Yield % is -2.27 as of Jul. 08, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Hinova Pharmaceuticals Business Description

Address No. 5 Keyuan South Road, No. 2 and 3, 4th Floor, Building 1, Rongyao Building, High-tech Zone, Sichuan Province, Chengdu, CHN, 610041
Hinova Pharmaceuticals Inc is an international drug company based on technology platforms such as deuterium and PROTAC, aiming to develop Best-in-class and First-in-class drugs with major clinical needs. The company focuses on the research and development of drugs in therapeutic areas such as oncology and metabolic diseases, focusing on providing safe, effective and affordable drugs for patients, and is committed to the development and production of drugs with global rights and interests.
24GF Score

Get the complete analysis for SHSE:688302

OCF Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

¥37.77
Price